These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8462126

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer.
    Propper DJ, Levitt NC, O'Byrne K, Braybrooke JP, Talbot DC, Ganesan TS, Thompson CH, Rajagopalan B, Littlewood TJ, Dixon RM, Harris AL.
    Br J Cancer; 2000 Jun; 82(11):1776-82. PubMed ID: 10839290
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A phase I study of the left-shifting agent BW12C79 plus mitomycin C and the effect on the skeletal muscle metabolism using 31P magnetic resonance spectroscopy.
    Philip PA, Thompson CH, Carmichael J, Rea D, Mitchell K, Taylor DJ, Stuart NS, Dennis I, Rajagopalan B, Ganesan T.
    Cancer Res; 1993 Dec 01; 53(23):5649-53. PubMed ID: 8242619
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic characteristics of 5-fluorouracil and mitomycin C in intraperitoneal chemotherapy.
    Kuzuya T, Yamauchi M, Ito A, Hasegawa M, Hasegawa T, Nabeshima T.
    J Pharm Pharmacol; 1994 Aug 01; 46(8):685-9. PubMed ID: 7815285
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical pharmacokinetics of high-dose mitomycin C.
    Schilcher RB, Young JD, Ratanatharathorn V, Karanes C, Baker LH.
    Cancer Chemother Pharmacol; 1984 Aug 01; 13(3):186-90. PubMed ID: 6386213
    [Abstract] [Full Text] [Related]

  • 13. The effects in volunteers of BW12C, a compound designed to left-shift the blood-oxygen saturation curve.
    Fitzharris P, McLean AE, Sparks RG, Weatherley BC, White RD, Wootton R.
    Br J Clin Pharmacol; 1985 Apr 01; 19(4):471-81. PubMed ID: 3994894
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A phase I-II study of continuous 5-day infusion mitomycin-C.
    Yap HY, Valdivieso M, Blumenschein G, Hortobagyi G, Bedikian A.
    Am J Clin Oncol; 1983 Feb 01; 6(1):109-12. PubMed ID: 6404154
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Population pharmacokinetics and pharmacodynamics of mitomycin during intraoperative hyperthermic intraperitoneal chemotherapy.
    van Ruth S, Mathôt RA, Sparidans RW, Beijnen JH, Verwaal VJ, Zoetmulder FA.
    Clin Pharmacokinet; 2004 Feb 01; 43(2):131-43. PubMed ID: 14748621
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mitomycin C pharmacokinetics in patients with recurrent or metastatic colorectal carcinoma.
    Erlichman C, Rauth AM, Battistella R, Fine S.
    Can J Physiol Pharmacol; 1987 Mar 01; 65(3):407-11. PubMed ID: 3107786
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.